
The global Spatial Genomics and Transcriptomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Spatial Genomics and Transcriptomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Spatial Genomics and Transcriptomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Spatial Genomics and Transcriptomics in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Spatial Genomics and Transcriptomics include 10x Genomics, Dovetail Genomics, Illumina, S2 Genomics, NanoString Technologies, Seven Bridges, Advanced Cell Diagnostics, ReadCoor and Horizon Discovery Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Spatial Genomics and Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spatial Genomics and Transcriptomics.
Report Scope
The Spatial Genomics and Transcriptomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Spatial Genomics and Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spatial Genomics and Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
10x Genomics
Dovetail Genomics
Illumina
S2 Genomics
NanoString Technologies
Seven Bridges
Advanced Cell Diagnostics
ReadCoor
Horizon Discovery Group
Segment by Type
Instruments
Consumables
Software
Segment by Application
Hospital
Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spatial Genomics and Transcriptomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spatial Genomics and Transcriptomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Software
1.3 Market by Application
1.3.1 Global Spatial Genomics and Transcriptomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spatial Genomics and Transcriptomics Market Perspective (2019-2030)
2.2 Spatial Genomics and Transcriptomics Growth Trends by Region
2.2.1 Global Spatial Genomics and Transcriptomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Spatial Genomics and Transcriptomics Historic Market Size by Region (2019-2024)
2.2.3 Spatial Genomics and Transcriptomics Forecasted Market Size by Region (2025-2030)
2.3 Spatial Genomics and Transcriptomics Market Dynamics
2.3.1 Spatial Genomics and Transcriptomics Industry Trends
2.3.2 Spatial Genomics and Transcriptomics Market Drivers
2.3.3 Spatial Genomics and Transcriptomics Market Challenges
2.3.4 Spatial Genomics and Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spatial Genomics and Transcriptomics Players by Revenue
3.1.1 Global Top Spatial Genomics and Transcriptomics Players by Revenue (2019-2024)
3.1.2 Global Spatial Genomics and Transcriptomics Revenue Market Share by Players (2019-2024)
3.2 Global Spatial Genomics and Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spatial Genomics and Transcriptomics Revenue
3.4 Global Spatial Genomics and Transcriptomics Market Concentration Ratio
3.4.1 Global Spatial Genomics and Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spatial Genomics and Transcriptomics Revenue in 2023
3.5 Spatial Genomics and Transcriptomics Key Players Head office and Area Served
3.6 Key Players Spatial Genomics and Transcriptomics Product Solution and Service
3.7 Date of Enter into Spatial Genomics and Transcriptomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spatial Genomics and Transcriptomics Breakdown Data by Type
4.1 Global Spatial Genomics and Transcriptomics Historic Market Size by Type (2019-2024)
4.2 Global Spatial Genomics and Transcriptomics Forecasted Market Size by Type (2025-2030)
5 Spatial Genomics and Transcriptomics Breakdown Data by Application
5.1 Global Spatial Genomics and Transcriptomics Historic Market Size by Application (2019-2024)
5.2 Global Spatial Genomics and Transcriptomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Spatial Genomics and Transcriptomics Market Size (2019-2030)
6.2 North America Spatial Genomics and Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Spatial Genomics and Transcriptomics Market Size by Country (2019-2024)
6.4 North America Spatial Genomics and Transcriptomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spatial Genomics and Transcriptomics Market Size (2019-2030)
7.2 Europe Spatial Genomics and Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Spatial Genomics and Transcriptomics Market Size by Country (2019-2024)
7.4 Europe Spatial Genomics and Transcriptomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spatial Genomics and Transcriptomics Market Size (2019-2030)
8.2 Asia-Pacific Spatial Genomics and Transcriptomics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Spatial Genomics and Transcriptomics Market Size by Region (2019-2024)
8.4 Asia-Pacific Spatial Genomics and Transcriptomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spatial Genomics and Transcriptomics Market Size (2019-2030)
9.2 Latin America Spatial Genomics and Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Spatial Genomics and Transcriptomics Market Size by Country (2019-2024)
9.4 Latin America Spatial Genomics and Transcriptomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spatial Genomics and Transcriptomics Market Size (2019-2030)
10.2 Middle East & Africa Spatial Genomics and Transcriptomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Spatial Genomics and Transcriptomics Market Size by Country (2019-2024)
10.4 Middle East & Africa Spatial Genomics and Transcriptomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Spatial Genomics and Transcriptomics Introduction
11.1.4 10x Genomics Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.1.5 10x Genomics Recent Development
11.2 Dovetail Genomics
11.2.1 Dovetail Genomics Company Detail
11.2.2 Dovetail Genomics Business Overview
11.2.3 Dovetail Genomics Spatial Genomics and Transcriptomics Introduction
11.2.4 Dovetail Genomics Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.2.5 Dovetail Genomics Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Spatial Genomics and Transcriptomics Introduction
11.3.4 Illumina Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.3.5 Illumina Recent Development
11.4 S2 Genomics
11.4.1 S2 Genomics Company Detail
11.4.2 S2 Genomics Business Overview
11.4.3 S2 Genomics Spatial Genomics and Transcriptomics Introduction
11.4.4 S2 Genomics Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.4.5 S2 Genomics Recent Development
11.5 NanoString Technologies
11.5.1 NanoString Technologies Company Detail
11.5.2 NanoString Technologies Business Overview
11.5.3 NanoString Technologies Spatial Genomics and Transcriptomics Introduction
11.5.4 NanoString Technologies Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.5.5 NanoString Technologies Recent Development
11.6 Seven Bridges
11.6.1 Seven Bridges Company Detail
11.6.2 Seven Bridges Business Overview
11.6.3 Seven Bridges Spatial Genomics and Transcriptomics Introduction
11.6.4 Seven Bridges Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.6.5 Seven Bridges Recent Development
11.7 Advanced Cell Diagnostics
11.7.1 Advanced Cell Diagnostics Company Detail
11.7.2 Advanced Cell Diagnostics Business Overview
11.7.3 Advanced Cell Diagnostics Spatial Genomics and Transcriptomics Introduction
11.7.4 Advanced Cell Diagnostics Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.7.5 Advanced Cell Diagnostics Recent Development
11.8 ReadCoor
11.8.1 ReadCoor Company Detail
11.8.2 ReadCoor Business Overview
11.8.3 ReadCoor Spatial Genomics and Transcriptomics Introduction
11.8.4 ReadCoor Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.8.5 ReadCoor Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group Spatial Genomics and Transcriptomics Introduction
11.9.4 Horizon Discovery Group Revenue in Spatial Genomics and Transcriptomics Business (2019-2024)
11.9.5 Horizon Discovery Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
10x Genomics
Dovetail Genomics
Illumina
S2 Genomics
NanoString Technologies
Seven Bridges
Advanced Cell Diagnostics
ReadCoor
Horizon Discovery Group
Ìý
Ìý
*If Applicable.
